Quantification of motor slowness in Parkinson's disease: Correlations between the tapping test and single joint ballistic movement parameters.

The tapping test is used routinely for the quantification of drug effects on motor slowness in Parkinson's disease (FD). This test has not been validated previously using reference methods measuring kinematic parameters of movement. We compared and correlated modifications of the tapping score induced by levodopa with that of kinematic parameters of a single joint ballistic movement in 10 PD patients. Results demonstrate that the modification of the tapping score correlates with the bradykinetic, but not the akinetic, component of motor slowness in PD. Also analyzed are the sensitivity and specificity of different thresholds of the increment of the tapping score for the detection of modifications in amplitude, velocity and acceleration. Using a tapping score threshold of positivity between 10 and 20% of increase, the sensitivity and specificity to detect significant modifications in velocity is 100%.

[1]  P. Piccini,et al.  Apomorphine test for dopaminergic responsiveness: A dose assessment study , 1993, Movement disorders : official journal of the Movement Disorder Society.

[2]  Giuliano Geminiani,et al.  Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study , 1991, Movement disorders : official journal of the Movement Disorder Society.

[3]  B. Bioulac,et al.  MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study , 1985, Brain Research.

[4]  A. Lees,et al.  The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[5]  Francesco Benvenuti,et al.  Human ballistic arm abduction movements , 1984, Neurology.

[6]  J. Nutt,et al.  Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon. , 1992, Archives of neurology.

[7]  C. Marsden,et al.  Slowness of movement in Parkinson's disease , 1989, Movement disorders : official journal of the Movement Disorder Society.

[8]  J. Morris,et al.  Reliability of the columbia scale for assessing signs of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[9]  M Hallett,et al.  Clinical neurophysiology of akinesia. , 1990, Revue neurologique.

[10]  E. Montgomery,et al.  Motor initiation versus execution in normal and Parkinson's disease subjects , 1991, Neurology.

[11]  W. Oertel,et al.  Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. , 1992, Archives of neurology.

[12]  P. Millac,et al.  The apomorphine test in parkinsonian syndromes. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[13]  M. Deahl.  Betel nut‐induced extrapyramidal syndrome: An unusual drug interaction , 1989, Movement disorders : official journal of the Movement Disorder Society.

[14]  E. Montgomery,et al.  Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions , 1991, Neurology.